AMRX
Price
$11.95
Change
-$0.23 (-1.89%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
3.83B
90 days until earnings call
Intraday BUY SELL Signals
PBH
Price
$60.06
Change
-$0.22 (-0.36%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
2.9B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRX vs PBH

Header iconAMRX vs PBH Comparison
Open Charts AMRX vs PBHBanner chart's image
Amneal Pharmaceuticals
Price$11.95
Change-$0.23 (-1.89%)
Volume$50.91K
Capitalization3.83B
Prestige Consumer Healthcare
Price$60.06
Change-$0.22 (-0.36%)
Volume$3.93K
Capitalization2.9B
AMRX vs PBH Comparison Chart in %
AMRX
Daily Signal:
Gain/Loss:
PBH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMRX vs. PBH commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and PBH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (AMRX: $12.18 vs. PBH: $60.28)
Brand notoriety: AMRX and PBH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 96% vs. PBH: 101%
Market capitalization -- AMRX: $3.83B vs. PBH: $2.9B
AMRX [@Pharmaceuticals: Generic] is valued at $3.83B. PBH’s [@Pharmaceuticals: Generic] market capitalization is $2.9B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 3 TA indicator(s) are bullish while PBH’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 3 bullish, 5 bearish.
  • PBH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PBH is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а -2.72% price change this week, while PBH (@Pharmaceuticals: Generic) price change was +1.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.75%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was +19.08%.

Reported Earning Dates

AMRX is expected to report earnings on Mar 04, 2026.

PBH is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.75% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($3.83B) has a higher market cap than PBH($2.9B). AMRX has higher P/E ratio than PBH: AMRX (1218.00) vs PBH (14.92). AMRX YTD gains are higher at: 53.788 vs. PBH (-22.807). AMRX has higher annual earnings (EBITDA): 584M vs. PBH (362M). PBH has more cash in the bank: 140M vs. AMRX (71.5M). PBH has less debt than AMRX: PBH (1.04B) vs AMRX (2.58B). AMRX has higher revenues than PBH: AMRX (2.85B) vs PBH (1.12B).
AMRXPBHAMRX / PBH
Capitalization3.83B2.9B132%
EBITDA584M362M161%
Gain YTD53.788-22.807-236%
P/E Ratio1218.0014.928,163%
Revenue2.85B1.12B255%
Total Cash71.5M140M51%
Total Debt2.58B1.04B248%
FUNDAMENTALS RATINGS
AMRX vs PBH: Fundamental Ratings
AMRX
PBH
OUTLOOK RATING
1..100
7813
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
4051
SMR RATING
1..100
9962
PRICE GROWTH RATING
1..100
3879
P/E GROWTH RATING
1..100
1279
SEASONALITY SCORE
1..100
2950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (83) in the Pharmaceuticals Other industry is in the same range as AMRX (100) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (40) in the Pharmaceuticals Major industry is in the same range as PBH (51) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to PBH’s over the last 12 months.

PBH's SMR Rating (62) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that PBH’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Price Growth Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for PBH (79) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than PBH’s over the last 12 months.

AMRX's P/E Growth Rating (12) in the Pharmaceuticals Major industry is significantly better than the same rating for PBH (79) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPBH
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
54%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 9 days ago
56%
Declines
ODDS (%)
Bearish Trend 15 days ago
73%
Bearish Trend 22 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signal:
Gain/Loss:
PBH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WWNPX120.735.04
+4.36%
Kinetics Paradigm No Load
LBWCX22.790.21
+0.93%
BrandywineGLOBAL Div US Large Value C
MPGVX17.360.09
+0.52%
Mondrian Global Equity Value
JUEZX27.880.14
+0.50%
JPMorgan US Equity R2
AFDCX55.380.16
+0.29%
American Century Large Cap Equity C

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with VTRS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+1.50%
VTRS - AMRX
45%
Loosely correlated
+1.21%
TEVA - AMRX
42%
Loosely correlated
+3.53%
AMPH - AMRX
42%
Loosely correlated
+3.41%
PAHC - AMRX
41%
Loosely correlated
+1.75%
BHC - AMRX
39%
Loosely correlated
+2.17%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.99%
PAHC - PBH
39%
Loosely correlated
+1.75%
IRWD - PBH
32%
Poorly correlated
+6.57%
AMRX - PBH
30%
Poorly correlated
+1.50%
ELAN - PBH
29%
Poorly correlated
-1.38%
ZTS - PBH
29%
Poorly correlated
-1.50%
More